Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

The document, from the US-China Economic and Security Review Commission, warns that if China did choose to restrict access to ...

PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in ...

Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.

Indian generics would soon become the backbone of the global HIV response. Within two years, the US launched PEPFAR, the ...

Bombay High Court halts Adwin Pharma from selling "ELGIMET" diabetes drugs due to potential confusion with "GLIMET" trademark.

On the banks of the Nile in Namasagali, where small-holder cassava farmers have long battled with falling prices and ...

The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...

At the Eastern Analytical Symposium (EAS) in Plainsboro, New Jersey, Purdue researchers presented data suggesting that microscopic flaws in drug crystals—rather than just chemical composition or ...